{"id":2880,"date":"2025-06-27T14:26:45","date_gmt":"2025-06-27T14:26:45","guid":{"rendered":"https:\/\/www.biogenera.com\/?p=2880"},"modified":"2025-07-19T08:52:48","modified_gmt":"2025-07-19T08:52:48","slug":"biogenera-protagonista-allo-swiss-biotech-day-2025-innovazione-e-network-internazionale","status":"publish","type":"post","link":"https:\/\/www.biogenera.com\/en\/biogenera-protagonista-allo-swiss-biotech-day-2025-innovazione-e-network-internazionale\/","title":{"rendered":"Biogenera at Swiss Biotech Day 2025: Innovation and International Dialogue"},"content":{"rendered":"<p class=\"translation-block\">Biogenera participated in the Swiss Biotech Day 2025, one of Europe\u2019s most prominent events in the biotechnology sector, held on May 5\u20136 at the Congress Center in Basel.<\/p>\n<p>It was a strategic occasion to strengthen our international relationships, present our ongoing R&amp;D programs, and engage in meaningful exchanges with key players in the global pharma-biotech landscape.<\/p>\n<p><strong>Institutional Presence<\/strong><\/p>\n<p class=\"translation-block\">Biogenera was represented by Massimiliano Cesarini (CEO &amp; Chairman) and Federico Ragni (Head of Business Development), who took part in one-to-one partnering meetings, industry roundtables, and extensive networking opportunities.<\/p>\n<p class=\"translation-block\">Our team introduced the progress of our proprietary MyGenera\u2122 platform, based on anti-gene oligonucleotides using Peptide Nucleic Acid (PNA) technology, and showcased the clinical development of BGA002, the world\u2019s first drug candidate targeting the MYCN oncogene, a key driver in aggressive pediatric and adult cancers.<\/p>\n<p><strong>Partnership and Vision<\/strong><\/p>\n<p>Swiss Biotech Day offered a unique opportunity to:<\/p>\n<ul>\n<li class=\"translation-block\">Consolidate scientific and industrial partnerships<\/li>\n<li class=\"translation-block\">Gather feedback from international experts<\/li>\n<li class=\"translation-block\">Explore licensing and co-development opportunities<\/li>\n<li class=\"translation-block\">Strengthen Biogenera\u2019s visibility within leading European biotech ecosystems<\/li>\n<\/ul>\n<p><strong>Looking Ahead<\/strong><\/p>\n<p class=\"translation-block\">Participating in high-level events like the Swiss Biotech Day reflects our commitment to advancing transformative science and making it accessible to those who need it most. As we approach the Phase I clinical trial of BGA002, Biogenera continues to engage with global partners to accelerate the delivery of breakthrough therapies.<\/p>","protected":false},"excerpt":{"rendered":"<p>Biogenera ha preso parte allo Swiss Biotech Day 2025, uno degli eventi pi\u00f9 importanti a livello europeo per il mondo biotech e farmaceutico, tenutosi il 5 e 6 maggio al Congress Center di Basilea. Un momento strategico per il settore e un\u2019opportunit\u00e0 concreta per rafforzare le relazioni internazionali, presentare i nostri progetti in corso e confrontarci con alcuni dei principali attori del panorama pharma-biotech globale. Una presenza istituzionale A rappresentare Biogenera erano presenti Massimiliano Cesarini (CEO e Chairman) e Federico Ragni (Head of Business Development), impegnati in incontri one-to-one, tavole rotonde e attivit\u00e0 di networking. Il team ha avuto modo di raccontare i progressi della nostra piattaforma proprietaria MyGenera&#x2122;, basata su oligonucleotidi anti-gene con tecnologia PNA (Peptide Nucleic Acid), e di presentare lo sviluppo clinico di BGA002, primo farmaco al mondo in grado di colpire selettivamente il gene MYCN, associato a forme tumorali pediatriche e adulte ad alta aggressivit\u00e0. Partnership e visione Lo Swiss Biotech Day ha rappresentato un&#8217;importante occasione per: Consolidare partnership scientifiche e industriali; Raccogliere feedback da esperti internazionali sul nostro approccio innovativo; Discutere di opportunit\u00e0 di partnership con potenziali partner industriali; Rafforzare la presenza di Biogenera nei principali ecosistemi biotech europei. Un futuro in costruzione La partecipazione a eventi di rilievo come lo Swiss Biotech Day conferma il nostro impegno nel rendere la ricerca scientifica accessibile e trasformativa. In questa fase cruciale, a pochi mesi di distanza dall\u2019inizio della Fase 1 clinica per BGA002, Biogenera continua a dialogare attivamente con i principali interlocutori internazionali per accelerare l\u2019arrivo di nuove terapie dove ce n\u2019\u00e8 pi\u00f9 bisogno.<\/p>","protected":false},"author":1,"featured_media":2906,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"om_disable_all_campaigns":false,"footnotes":""},"categories":[11],"tags":[],"class_list":["post-2880","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-evento"],"_links":{"self":[{"href":"https:\/\/www.biogenera.com\/en\/wp-json\/wp\/v2\/posts\/2880","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.biogenera.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.biogenera.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.biogenera.com\/en\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.biogenera.com\/en\/wp-json\/wp\/v2\/comments?post=2880"}],"version-history":[{"count":1,"href":"https:\/\/www.biogenera.com\/en\/wp-json\/wp\/v2\/posts\/2880\/revisions"}],"predecessor-version":[{"id":2882,"href":"https:\/\/www.biogenera.com\/en\/wp-json\/wp\/v2\/posts\/2880\/revisions\/2882"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.biogenera.com\/en\/wp-json\/wp\/v2\/media\/2906"}],"wp:attachment":[{"href":"https:\/\/www.biogenera.com\/en\/wp-json\/wp\/v2\/media?parent=2880"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.biogenera.com\/en\/wp-json\/wp\/v2\/categories?post=2880"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.biogenera.com\/en\/wp-json\/wp\/v2\/tags?post=2880"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}